Lexicon Pharmaceuticals, Inc.

US$1.78As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LXRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (19.07%)
Div yield —
ROE (43.91%)
Biotechnology
Beta (5Y) 1.08
PE TTM —
TSR TTM 28.99%
Mkt cap US$792.5M
ROIC (17.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.92
8.05%
177.33%
Hold 6|11|12|3|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
24.05%
13.75%
11.71%
8.66%
Revenue$M
50.16
50.82
50.97
50.16
5.55%
2.23%
4.34%
5.08%
Peers (US$792.5M)
Cap (US$)
PE
796.2M
—
780.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.304
1.671
1.698
EBIT/Intx
0.773
0.190
0.230
Own earn%
28.91
(34.26)
(24.78)
Sh yield%
40.74
37.23
36.91
Owners
Insiders/Inst%
2.11
86.25
Short interest%
1.69
SBC / revenue%
0.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
0–3
$1 testx
15.2
Incr. ROIC%
3